NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financi... ($7.4 million for the full year 2007. Th...)

NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results

Date:4/1/2009

$7.4 million for the full year 2007. The increase was primarily attributable to an increase in development/clinical expenses and higher employee costs due to an increase in headcount.

General and administrative expenses totaled $5.6 million for the year ended December 31, 2008, compared with $4.4 million for the year-ago period. This increase was due in part to an increase in employee costs and related increases in other employee benefits and recruiting expenses

About NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals is a mid-stage biopharmaceutical company focused on developing its proprietary and patented Aganocide compounds, first-in-class, novel, synthetic anti-infective product candidates that are bioequivalent to the active antimicrobial molecules generated within white blood cells to treat and prevent a wide range of infections without causing resistance. NovaBay has internal development programs aimed at addressing hospital and respiratory infections. The company has a licensing and research collaboration agreement with Alcon, Inc. for use of its Aganocides in the eye, ear and sinus, and in contact lens solutions. NovaBay has entered into an agreement with Galderma S.A. to develop and commercialize Aganocides in acne, impetigo and other dermatological indications. NovaBay(R) and Aganocide(R) are trademarks of NovaBay Pharmaceuticals, Inc. For more information on NovaBay, visit www.novabaypharma.com.

Forward-Looking Statements

This release contains forward-looking statements, which are based upon management's current expectations, assumptions, estimates, projections and beliefs. Statements regarding NovaBay's expectations of its 2009 cash burn, anticipation of proof-of-concept data later in 2009 on its earlier-stage internal pipeline programs, that it will receive from Galderma up to $50 million
'/>"/>

SOURCE NovaBay Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:6/19/2013)... Washington (PRWEB) June 18, 2013 A ... complex materials, costs and other trends will highlight technical ... Monterey, California this fall. In its 33rd year, the ... includes an exhibition of key suppliers, approximately 100 technical ... SPIE, the international society for optics and photonics ...

(Date:6/18/2013)... 18, 2013 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced its preliminary unaudited financial results for the fourth ... March 31, 2013. Fourth Quarter of ... quarter of fiscal 2013 increased by 33.3% to RMB133.0 ...

(Date:6/18/2013)... The human skin is the largest organ, ... human body part. Similar to the liver, or heart, the ... repair and grow. Recent reports from the mankatofreepress.com explained how ... as important as other life supporting organs. The article suggests ... cell reproduction, increase the appearance of skin, and fight off ...

(Date:6/18/2013)... 2013 regulated information — Global biopharmaceutical company UCB, ... announced the launch of a new Pledge campaign for ... The Pledge empowers the millions of Americans ... a personal commitment to demand more: greater understanding of ... and additional partial-onset seizure control. More information is available ...

[0] ‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology [0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 [0] Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin [0] Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy

... 4 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:,ONC, NASDAQ: ... his research group at The Institute of Cancer ... testing combination treatment schedules,of reovirus and radiation in ... in,vivo. The paper, entitled "Enhanced In vitro and ...

... 2008) -- A University of Waterloo physics and astronomy ... in Science Magazine, shows how some solids behave like ... James Forrest and then-graduate student Zahra Fakhraai, take a ... substances using nanoscale technology. , They explore the properties ...

... 1 MannKind Corporation,(Nasdaq: MNKD ), focused on ... today that it will present at,the Merrill Lynch Global ... at 1:40 PM ET at the Grand Hyatt Hotel ... link to the live web cast of the,presentation in ...

Cached Biology Technology:Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy 2 UW paper in Science shows how some solids mimic liquids on nanoscale 2

Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy UW paper in Science shows how some solids mimic liquids on nanoscale MannKind to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference

(Date:6/18/2013)... the United Kingdom, the Energy Department,s National Renewable ... have recently published a paper describing a novel ... Limnoria quadripunctata , commonly known as the gribble. ... exhibit a relatively unique ability to produce their ... break down the biomass they eat. New biomass-degrading ...

(Date:6/18/2013)... Research Council, Laboratory of Molecular Biology, has been ... Young Investigator Award. Torrent is being recognized for ... algorithm to predict antimicrobial regions in proteins. Luis ... now applying this algorithm to interrogate full genomes ... with very appealing results." , Torrent obtained ...

(Date:6/18/2013)... 18, 2013 The herbal extract of a yellow-flowered ... to increase the lifespan of fruit fly populations by ... researchers. , But it,s how Rhodiola ... that grabbed the attention of study leaders Mahtab Jafari ... works in a manner completely unrelated to dietary restriction ...

Breaking Biology News(10 mins):Novel enzyme from tiny gribble could prove a boon for biofuels research 2 The American Society for Microbiology honors Marc Torrent 2 Herbal extract boosts fruit fly lifespan by nearly 25 percent, UCI study finds 2

[0] Novel enzyme from tiny gribble could prove a boon for biofuels research [0] The American Society for Microbiology honors Marc Torrent [0] Herbal extract boosts fruit fly lifespan by nearly 25 percent, UCI study finds

... In nature, ultraviolet radiation from sunlight is not the ... and females who choose to lay their eggs in the ... amphibian species out of harm,s way most of the time, ... of the long-toed salamander received lethal doses of UV across ...

... Researchers from the p53 Laboratory of Singapore,s Agency for ... makes feasible a unique method of cancer treatment. Their work, ... Differentiation today , offers new insight on how to ... genome, , to more effectively kill cancer cells while sparing ...

... 2010) - A technique pioneered in the Tissue Engineering ... Edward V. Zegarelli Professor of Dental Medicine at Columbia ... to a three-dimensional scaffold infused with growth factor, holding ... in as soon as nine weeks once implanted. ...

Cached Biology News:Ultraviolet radiation not culprit killing amphibians, research shows 2 Ultraviolet radiation not culprit killing amphibians, research shows 3 Singapore scientists exploit knowledge of p53 for increasing specificity of cancer treatments 2 Technique yields potential biological substitute for dental implants 2

Ultraviolet radiation not culprit killing amphibians, research shows Singapore scientists exploit knowledge of p53 for increasing specificity of cancer treatments Technique yields potential biological substitute for dental implants

Anti-TWIK-1 Immunogen: Purified peptide from amino acids 53-69 of human TWIK-1 (Accession number O00180)....

Monoclonal 8C2.1 is specific for Bunyavirus G1 as tested by neutralization, immunoprecipitation and immunobinding assays....

BI-1 Polyclonal Antibody Storage Temperature: -20C Shipping: gel pack Shelf-Life: 12 months...

...

Biology Products:

Rabbit Anti-TWIK-1 Antibody, Unconjugated from CHEMICON Anti-Bunyavirus (G1) Monoclonal Antibody, Unconjugated, Clone 8C2.1 from CHEMICON Rabbit Anti-BI-1 Polyclonal Antibody, Unconjugated from BioVision Capped Xef-1 RNA 0.05 ml from Ambion